drugset / Trial / NCT04165850
Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, off label study, to provide interested ALS patients with Ciprofloxacin/Celecoxib fixed dose combination, while assessing safety and tolerability and routine disease progression measures (ALSFRS-R and Vital Capacity).
Timeline
- Start
- 2019-11-25
- Primary completion
- 2021-01-19
- Completion
- 2021-01-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | — | — |
| Subject | Ciprofloxacin | Small molecule | — | — |